Sheila Francis Selected Research

Doxorubicin (Adriamycin)

7/2021

IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheila Francis Research Topics

Disease

9	Inflammation (Inflammations) 11/2021 - 04/2006
8	Atherosclerosis 01/2018 - 01/2009
2	Infarction (Infarctions) 11/2021 - 01/2019
2	Myocardial Infarction 11/2021 - 01/2019
2	Neuroinflammatory Diseases 01/2019 - 08/2011
2	Brain Injuries (Brain Injury) 01/2019 - 05/2014
2	Pulmonary Arterial Hypertension 01/2018 - 01/2008
2	Stroke (Strokes) 06/2012 - 08/2011
2	Atherosclerotic Plaque (Atheroma) 09/2011 - 01/2009
2	Neointima 01/2010 - 04/2006
1	Ventricular Remodeling 11/2021
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Neoplasm Metastasis (Metastasis) 07/2021
1	Ischemic Stroke 01/2019
1	Edema (Dropsy) 01/2019
1	Hyperalgesia 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Pain (Aches) 01/2019
1	Complex Regional Pain Syndromes 01/2019
1	Thrombosis (Thrombus) 10/2014
1	Brain Ischemia (Cerebral Ischemia) 05/2014
1	Infections 05/2014
1	Dementia (Dementias) 06/2012
1	Obesity 01/2012
1	Bacterial Infections (Bacterial Infection) 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2011
1	Insulin Resistance 09/2011
1	Necrosis 04/2011
1	Arteritis 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2006

Drug/Important Bio-Agent (IBA)

8	Interleukin-1 (Interleukin 1)IBA 07/2021 - 04/2006
4	CytokinesIBA 07/2021 - 01/2009
4	ApolipoproteinsIBA 01/2018 - 04/2011
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2021 - 04/2006
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2021 - 01/2010
2	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2009
2	InterleukinsIBA 05/2014 - 04/2006
2	LipidsIBA 01/2012 - 08/2011
1	sodium boranocarbonateIBA 11/2021
1	Carbon MonoxideIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021
1	Zoledronic Acid (Zometa)FDA Link 07/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Cre recombinaseIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	EndotoxinsIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 01/2019
1	Endothelins (Endothelin)IBA 01/2018
1	macitentanIBA 01/2018
1	Platelet Membrane GlycoproteinsIBA 05/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2014
1	Glycoproteins (Glycoprotein)IBA 01/2014
1	ProperdinIBA 01/2014
1	Complement System Proteins (Complement)IBA 01/2012
1	CholesterolIBA 01/2012
1	Fibroblast Growth Factor-23IBA 09/2011
1	Phosphates (Orthophosphate)IBA 09/2011
1	C-Reactive ProteinIBA 08/2011
1	LigandsIBA 04/2011
1	OsteoprotegerinIBA 01/2008
1	Serotonin (5 Hydroxytryptamine)IBA 01/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 04/2006

Therapy/Procedure

1	Therapeutics 07/2021
1	Percutaneous Coronary Intervention 10/2014
1	Stents 10/2014
1	Ligation 04/2006